Literature DB >> 2293022

Expression of two forms of prolactin receptor in rat ovary and liver.

M Shirota1, D Banville, S Ali, C Jolicoeur, J M Boutin, M Edery, J Djiane, P A Kelly.   

Abstract

The screening of a size-selected cDNA library from the ovary revealed the existence of a second form of PRL receptor in the rat. The polypeptide sequence deduced from cDNAs has a much longer cytoplasmic domain (357 amino acids) than the form previously identified in the liver (57 amino acids). Nucleotide sequence analysis and comparison with rabbit, mouse, and human PRL receptor cDNAs suggests that the two forms of rat PRL receptor result from alternative splicing of a primary transcript. Complementary DNAs encoding the long form of the receptor were also found in a library prepared from estradiol-treated rat liver, although they represent a minor fraction of total PRL receptor cDNAs obtained from this tissue. DNA polymerase chain reaction amplification of cDNA confirmed the presence of the two receptor forms in both the ovary and liver. Northern analysis, using probes that specifically hybridize with either form of mRNA, indicates a major transcript of 1.8 kilobases (kb) in estradiol-treated liver, which encodes the receptor with a short cytoplasmic domain, while the long form of the receptor is encoded by mRNAs of 2.5 and 3 kb. In the ovary, a complex pattern of hybridization to multiple mRNAs (1.8-5.5 kb) is obtained with the probe specific to the long form, and essentially only a 5.5-kb mRNA is obtained with the probe specific to the short form. The predicted size of the mature form of the long PRL receptor (PRL-R2) is 591 amino acid residues.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2293022     DOI: 10.1210/mend-4-8-1136

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  28 in total

Review 1.  Gender dimorphism in immune responses following trauma and hemorrhage.

Authors:  Yukihiro Yokoyama; Martin G Schwacha; T S Anantha Samy; Kirby I Bland; Irshad H Chaudry
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Using gene expression arrays to elucidate transcriptional profiles underlying prolactin function.

Authors:  Sandra Gass; Jessica Harris; Chris Ormandy; Cathrin Brisken
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

3.  Modulation of growth factor receptor function by isoform heterodimerization.

Authors:  W P Chang; C V Clevenger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

4.  Prolactin and prolactin receptors are expressed and functioning in human prostate.

Authors:  M T Nevalainen; E M Valve; P M Ingleton; M Nurmi; P M Martikainen; P L Harkonen
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

5.  Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription.

Authors:  L Lesueur; M Edery; S Ali; J Paly; P A Kelly; J Djiane
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

6.  Anxiolytic and anti-stress effects of brain prolactin: improved efficacy of antisense targeting of the prolactin receptor by molecular modeling.

Authors:  L Torner; N Toschi; A Pohlinger; R Landgraf; I D Neumann
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

7.  Regulation of the rat liver sodium-dependent bile acid cotransporter gene by prolactin. Mediation of transcriptional activation by Stat5.

Authors:  T C Ganguly; M L O'Brien; S J Karpen; J F Hyde; F J Suchy; M Vore
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

8.  Association between vascular endothelial growth factor promoter polymorphisms and the risk of recurrent implantation failure.

Authors:  Sung Han Shim; Jung Oh Kim; Young Joo Jeon; Hui Jeong An; Hyun Ah Lee; Ji Hyang Kim; Eun Hee Ahn; Woo Sik Lee; Nam Keun Kim
Journal:  Exp Ther Med       Date:  2017-12-15       Impact factor: 2.447

9.  Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF-4EBP1-Mediated Cell Death in Uterine Cancer.

Authors:  Yunfei Wen; Ying Wang; Anca Chelariu-Raicu; Elaine Stur; Yuan Liu; Sara Corvigno; Faith Bartsch; Lauren Redfern; Behrouz Zand; Yu Kang; Jinsong Liu; Keith Baggerly; Anil K Sood
Journal:  Mol Cancer Ther       Date:  2020-07-31       Impact factor: 6.261

10.  Inhibition of gonadotropin hormone-releasing hormone release by prolactin from GT1 neuronal cell lines through prolactin receptors.

Authors:  L Milenković; G D'Angelo; P A Kelly; R I Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.